Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 17.00
-0.21 (-1.22%)
May 12, 2026, 3:00 PM CST
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 7.24 billion as of May 12, 2026. Its market cap has increased by 57.46% in one year.
Market Cap
7.24B
Enterprise Value
7.54B
Revenue
699.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.00
Market Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 7.24B, a decrease of -44.24%. That is a compound annual growth rate of -9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.24B | 5.39% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |
| Shanghai Medicilon | 8.06B |
| Acrobiosystems | 7.69B |
| Chengdu Kanghua Biological Products | 7.55B |
| Suzhou Fengbei Biotech Stock | 7.28B |
| Shanghai OPM Biosciences | 7.23B |
| Xiangxue Pharmaceutical | 6.99B |